N. Osuji, K. Beiske, U. Randen, E. Matutes, G. Tjonnfjord et al., Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia, Histopathology, vol.58, issue.5, pp.547-554, 2007.
DOI : 10.1097/01.pas.0000160732.43909.3f

H. Evans, E. Burks, D. Viswanatha, and R. Larson, Utility of immunohistochemistry in bone marrow evaluation of T-lineage large granular lymphocyte leukemia, Human Pathology, vol.31, issue.10
DOI : 10.1053/hupa.2000.19298

R. Zambello, T. Berno, G. Cannas, I. Baesso, G. Binotto et al., Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL), Blood, vol.106, issue.12, pp.3926-3931, 2005.
DOI : 10.1182/blood-2005-05-1972

A. Mailloux, L. Zhang, L. Moscinski, J. Bennett, L. Yang et al., Fibrosis and Subsequent Cytopenias Are Associated with Basic Fibroblast Growth Factor-Deficient Pluripotent Mesenchymal Stromal Cells in Large Granular Lymphocyte Leukemia, The Journal of Immunology, vol.191, issue.7, pp.3578-3593, 2013.
DOI : 10.4049/jimmunol.1203424

T. Lamy and T. Loughran, Current concepts: large granular lymphocyte leukemia, Blood Reviews, vol.13, issue.4, pp.230-270, 1999.
DOI : 10.1054/blre.1999.0118

E. Poullot, R. Zambello, F. Leblanc, B. Bareau, D. March et al., Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients, Annals of Oncology, vol.25, issue.10, pp.2030-2035, 2014.
DOI : 10.1093/annonc/mdu369

URL : https://hal.archives-ouvertes.fr/hal-01058902

R. Watters, X. Liu, and T. Loughran, T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias, Leukemia & Lymphoma, vol.55, issue.12, pp.2217-2242, 2011.
DOI : 10.1111/j.1365-2141.2006.06429.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721966

S. Steinway, F. Leblanc, and T. Loughran, The pathogenesis and treatment of large granular lymphocyte leukemia, Blood Reviews, vol.28, issue.3, pp.87-94, 2014.
DOI : 10.1016/j.blre.2014.02.001

R. Go, C. Li, A. Tefferi, and R. Phyliky, Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes, Blood, vol.98, issue.2, pp.483-488, 2001.
DOI : 10.1182/blood.V98.2.483

J. Liu, S. Wei, T. Lamy, Y. Li, P. Epling-burnette et al., Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia, Blood, vol.100, issue.4, pp.1449-1453, 2002.

R. Kothapalli, S. Nyland, I. Kusmartseva, R. Bailey, T. Mckeown et al., Constitutive production of proinflammatory cytokines Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia, Blood, vol.121, pp.3843-3854, 2013.

A. Viny, A. Lichtin, B. Pohlman, T. Loughran, and J. Maciejewski, Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia, Leukemia & Lymphoma, vol.72, issue.5, pp.932-940, 2008.
DOI : 10.7326/0003-4819-146-9-200705010-00009

R. Zhang, M. Shah, and T. Loughran, The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders, Hematological Oncology, vol.22, issue.2, pp.105-122, 2010.
DOI : 10.1093/gerona/53A.3.B196

L. Sokol, L. Jr, and T. , Large Granular Lymphocyte Leukemia, The Oncologist, vol.11, issue.3, pp.263-73, 2006.
DOI : 10.1634/theoncologist.11-3-263

A. Audemard, T. Lamy, B. Bareau, F. Sicre, F. Suarez et al., Vasculitis associated with large granular lymphocyte (LGL) leukemia: Presentation and treatment outcomes of 11 cases, Seminars in Arthritis and Rheumatism, vol.43, issue.3, pp.362-368, 2013.
DOI : 10.1016/j.semarthrit.2013.07.002

P. Murphy, L. Brett, E. Verla-tebit, B. Macik, and T. Loughran, Acquired inhibitors to factor VIII and fibrinogen in the setting of T-cell large granular lymphocyte leukemia, Blood Coagulation & Fibrinolysis, vol.26, issue.2, pp.211-213, 2015.
DOI : 10.1097/MBC.0000000000000209

S. Greenberg, J. Pinkus, A. Amato, T. Kristensen, and D. Dorfman, Association of inclusion body myositis with T cell large granular lymphocytic leukaemia, Brain, vol.139, issue.5, pp.1348-60, 2016.
DOI : 10.1093/brain/aww024

L. Rossoff, J. Genovese, M. Coleman, and D. Dantzker, Primary Pulmonary Hypertension in a Patient With CD8/T-cell Large Granulocyte Leukemia*, Chest, vol.112, issue.2, pp.551-554, 1997.
DOI : 10.1378/chest.112.2.551

R. Zhang, M. Shah, Y. J. Nyland, S. Liu, X. Yun et al., Network model of survival signaling in large granular lymphocyte leukemia, Proceedings of the National Academy of Sciences, vol.24, issue.2, pp.16308-16313, 2008.
DOI : 10.1093/bioinformatics/btm571

G. Starkebaum, T. Loughran, V. Kalyanaraman, M. Kadin, P. Kidd et al., SERUM REACTIVITY TO HUMAN T-CELL LEUKAEMIA/LYMPHOMA VIRUS TYPE I PROTEINS IN PATIENTS WITH LARGE GRANULAR LYMPHOCYTIC LEUKAEMIA, The Lancet, vol.329, issue.8533, pp.596-605, 1987.
DOI : 10.1016/S0140-6736(87)90236-4

L. Sokol, D. Agrawal, and T. Loughran, Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia, Leukemia Research, vol.29, issue.4, pp.381-388, 2005.
DOI : 10.1016/j.leukres.2004.08.010

H. Prototypical, II infection is rare in LGL leukemia, Leuk Res, vol.18, issue.6, pp.423-432, 1994.

R. Pawson, T. Schulz, E. Matutes, and D. Catovsky, The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia, Leukemia, vol.11, issue.8, pp.1305-1316, 1997.
DOI : 10.1038/sj.leu.2400725

T. Loughran, T. Coyle, M. Sherman, G. Starkebaum, G. Ehrlich et al., Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia, Blood, vol.80, issue.5, pp.1116-1125, 1992.

W. Heneine, W. Chan, J. Lust, S. Sinha, S. Zaki et al., HTLV-II infection is rare in patients with large granular lymphocyte leukemia, J Acquir Immune Defic Syndr, vol.7, issue.7, pp.736-743, 1994.

P. Johansson, A. Bergmann, S. Rahmann, I. Wohlers, R. Scholtysik et al., (A20) in T-cell large granular lymphocytic leukemia, International Journal of Cancer, vol.971, issue.1, pp.121-124, 2016.
DOI : 10.1007/978-1-62703-269-8_1

M. Shah, R. Zhang, R. Irby, R. Kothapalli, X. Liu et al., Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes, Blood, vol.112, issue.3, pp.770-781, 2008.
DOI : 10.1182/blood-2007-11-121871

F. Leblanc, X. Liu, J. Hengst, T. Fox, V. Calvert et al., Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia, Cancer Biology & Therapy, vol.26, issue.12, pp.1830-1840, 2015.
DOI : 10.1139/o59-099

X. Liu, L. Ryland, Y. J. Liao, A. Aliaga, C. Watts et al., Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia, Blood, vol.116, issue.20, pp.4192-4201, 2010.
DOI : 10.1182/blood-2010-02-271080

R. Kothapalli, I. Kusmartseva, and T. Loughran, Characterization of a human sphingosine-1-phosphate receptor gene (S1P5) and its differential expression in LGL leukemia, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1579, issue.2-3, pp.2-3, 2002.
DOI : 10.1016/S0167-4781(02)00529-8

F. Pandolfi, T. Loughran, G. Starkebaum, T. Chisesi, T. Barbui et al., Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study, Cancer, vol.313, issue.2, pp.341-349, 1990.
DOI : 10.1111/j.1600-0609.1986.tb01779.x

P. Litam, H. Friedman, and T. Loughran, Splenic Extramedullary Hematopoiesis in a Patient Receiving Intermittently Administered Granulocyte ColonyStimulating Factor, Annals of Internal Medicine, vol.118, issue.12, pp.954-959, 1993.
DOI : 10.7326/0003-4819-118-12-199306150-00007

T. Lamy, P. Leprise, L. Amiot, B. Drenou, R. Fauchet et al., Response to granulocyte-macrophage colony-stimulating factor (GM-CSF) but not to G- CSF in a case of agranulocytosis associated with large granular lymphocyte (LGL) leukemia, Blood, vol.85, issue.11, pp.3352-3355, 1995.

T. Loughran, P. Kidd, and G. Starkebaum, Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate, Blood, vol.84, issue.7, pp.2164-2170, 1994.

N. Fujishima, K. Sawada, M. Hirokawa, K. Oshimi, K. Sugimoto et al., successful treatment with rituximab, Acta Reumatol Port, p.26337633, 2015.

D. Cornec, V. Devauchelle-pensec, S. Jousse-joulin, T. Marhadour, V. Ugo et al., Long-term remission of T-cell large granular lymphocyte leukemia associated with rheumatoid arthritis after rituximab therapy, Blood, vol.122, issue.9, pp.1583-1589, 2013.
DOI : 10.1182/blood-2013-03-491464

V. Subbiah, A. Viny, S. Rosenblatt, B. Pohlman, A. Lichtin et al., Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia, Experimental Hematology, vol.36, issue.9, pp.1078-1083, 2008.
DOI : 10.1016/j.exphem.2008.04.005

M. V. Dhodapkar, C. Li, J. Lust, A. Tefferi, and R. Phyliky, Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?, Blood, vol.84, issue.5, pp.1620-1627, 1994.

T. Waldmann, K. Conlon, D. Stewart, T. Worthy, J. Janik et al., Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia, Blood, vol.121, issue.3, pp.476-484, 2013.
DOI : 10.1182/blood-2012-08-450585

P. Epling-burnette, L. Sokol, X. Chen, F. Bai, J. Zhou et al., Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling, Blood, vol.112, issue.12, pp.4694-4698, 2008.
DOI : 10.1182/blood-2008-02-136382

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597136

F. Hayakawa, K. Sugimoto, Y. Harada, N. Hashimoto, N. Ohi et al., A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases, Blood Cancer Journal, vol.96, issue.11, p.166, 2013.
DOI : 10.1182/blood-2010-04-261867